Male Check-up Clinic in Goyang — AUD Prices

Professor Park Jung-won is a leading Korean specialist in hepatocellular carcinoma with over 30 years of experience. He is the Director of the Liver and Liver Cancer Center and the Integrated Cancer Care Center at Myongji Hospital. He led Korea’s first HCC guidelines in 2003. He has also overseen their updates for about 20 years. His team validated proton beam radiotherapy for liver cancer, as published in the Journal of Hepatology. He has authored more than 200 SCI-indexed papers. He also helped lead global trials, including the 2025 CheckMate 9DW study, which showed improved outcomes with nivolumab plus ipilimumab for unresectable HCC.

MD/PhD, Seoul National University; Member, National Academy of Medicine of Korea; former President, Korean Liver Cancer Association; Chair, Korean HCC Guidelines Committee; Prime Minister’s and Health Minister’s commendations; Pfizer Medical Research Award and Roche Oncology Academic Award.

Dr. Tae-Yung Jung, MD, PhD, is a Clinical Professor of Urology at Myongji Hospital and Director of the Medical Cooperation Center. Myongji Hospital is an educational partner of Hanyang University. He previously served as an Associate Professor at Kwandong University College of Medicine.

His clinical focus includes urinary tract stones (urolithiasis), voiding dysfunction, prostate-related urinary symptoms, and overactive bladder.

He has published several papers on urinary stones and voiding disorders. He earned his MD and MS from Hanyang University and his PhD from Chungnam National University. He is a member of the Korean Urological Association, Korean Endourological Society, Korean Prostate Society, Korean Continence Society, and Korean Urological Oncology Society.